13. Older Adults: Standards of Medical Care in Diabetes-2022

被引:94
作者
American Diabetes Association Professional Practice Committee*
机构
关键词
LIFE-STYLE INTERVENTION; MILD COGNITIVE IMPAIRMENT; QUALITY-OF-LIFE; DIABETES-MELLITUS; POSITION STATEMENT; CARDIOVASCULAR OUTCOMES; GLUCOSE CONTROL; HYPOGLYCEMIC MEDICATIONS; INTRANASAL INSULIN; ALZHEIMERS-DISEASE;
D O I
10.2337/dc22-S013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc22-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc22-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
引用
收藏
页码:S195 / S207
页数:13
相关论文
共 124 条
[121]   Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association [J].
Young-Hyman, Deborah ;
de Groot, Mary ;
Hill-Briggs, Felicia ;
Gonzalez, Jeffrey S. ;
Hood, Korey ;
Peyrot, Mark .
DIABETES CARE, 2016, 39 (12) :2126-2140
[122]   Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years A Meta-analysis [J].
Yourman, Lindsey C. ;
Cenzer, Irena S. ;
Boscardin, W. John ;
Nguyen, Brian T. ;
Smith, Alexander K. ;
Schonberg, Mara A. ;
Schoenborn, Nancy L. ;
Widera, Eric W. ;
Orkaby, Ariela ;
Rodriguez, Annette ;
Lee, Sei J. .
JAMA INTERNAL MEDICINE, 2021, 181 (02) :179-185
[123]  
Zhang James X, 2018, J Health Med Econ, V4, DOI 10.21767/2471-9927.100040
[124]   Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes [J].
Edwards, Jonathan L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (11) :1093-1093